Literature DB >> 23291947

Autologous heat-shock protein vaccines.

Camilo Colaco1.   

Abstract

An alternative explanation for the variable immunogenicity of Vitespan in clinical trials.

Keywords:  cancer vaccines; gp96; heat shock proteins; hsp70; hsp90

Mesh：

Substances：

Year:  2013        PMID： 23291947      PMCID： PMC3859746          DOI： 10.4161/hv.22652

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  14 in total

Review 1.  The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.

Authors:  H Singh-Jasuja; N Hilf; H U Scherer; D Arnold-Schild; H G Rammensee; R E Toes; H Schild
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

2.  Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.

Authors:  P K Srivastava; N S Jaikaria
Journal:  Methods Mol Biol       Date:  2001

Review 3.  A Grp on the Hsp90 mechanism.

Authors:  Klaus Richter; Jochen Reinstein; Johannes Buchner
Journal:  Mol Cell       Date:  2007-10-26       Impact factor: 17.970

Review 4.  Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

Authors:  P K Srivastava
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

5.  Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study.

Authors:  S Janetzki; D Palla; V Rosenhauer; H Lochs; J J Lewis; P K Srivastava
Journal:  Int J Cancer       Date:  2000-10-15       Impact factor: 7.396

Review 6.  Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity.

Authors:  Christopher V Nicchitta
Journal:  Nat Rev Immunol       Date:  2003-05       Impact factor: 53.106

7.  Tumor rejection antigens of chemically induced sarcomas of inbred mice.

Authors:  P K Srivastava; A B DeLeo; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  A mouse tumor-specific transplantation antigen is a heat shock-related protein.

Authors:  S J Ullrich; E A Robinson; L W Law; M Willingham; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.

Authors:  Z Li; P K Srivastava
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

10.  Heat shock protein 70-associated peptides elicit specific cancer immunity.

Authors:  H Udono; P K Srivastava
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307
View more
  2 in total

Review 1.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

Review 2.  Heat-shock proteins as dendritic cell-targeting vaccines--getting warmer.

Authors:  Shaun McNulty; Camilo A Colaco; Lucy E Blandford; Christopher R Bailey; Selene Baschieri; Stephen Todryk
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.